RE:RE:Isn’t this down another 50% since September report?wofats wrote: Isn't this in play this quarter? If yes it is another 12M loss on this investment quarter on quarter.
As well
On the 40M ebida are not we at 56M now? Setting the bar fairly low perhaps.
Do you mean the current quarter or Q1? I guess it's in play for both but the Q1 unrealized loss will be around $7M (since it closed Q1 at $6.31) as per the annual report:
"On May 26, 2021 Singular Genomics Systems, Inc. (“SGS”), an investment held within Domain Associated LLC (“Domain”), announced the closing of its initial public offering at a public offering price of USD 22 per share. The Company recorded an unrealized gain of $10,962 [USD 9,100] during the year ended December 31, 2021 and a life to date unrealized gain of $13,772 [USD 11,215] in connection with SGS. As at March 21, 2022, SGS’s share price closed at USD 6.34. Should the share price of SGS remain at this level, the Company would record an unrealized loss of approximately $7,050 [USD 5,599]." It's come down 15% since then so yes, more unrealized losses to come from this unless something changes before the end of the quarter.